BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34284745)

  • 1. The combination of
    Zhang F; He Q; Luo G; Long Y; Li R; Ding L; Zhang X
    BMC Cancer; 2021 Jul; 21(1):837. PubMed ID: 34284745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical application of combination [
    Wang Z; Feng Z; Zhu D; Wang X; Chen J; Zhu Y; Wang H
    BMC Endocr Disord; 2024 Feb; 24(1):19. PubMed ID: 38311763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of suprasellar meningiomas from non-functioning pituitary macroadenomas by
    Ding L; Zhang F; He Q; Li Z; Shi X; Li R; Zhang X
    BMC Cancer; 2020 Jun; 20(1):564. PubMed ID: 32552842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of (68)Ga DOTATATE to 18F-FDG uptake is useful in the differentiation of residual or recurrent pituitary adenoma from the remaining pituitary tissue after transsphenoidal adenomectomy.
    Zhao X; Xiao J; Xing B; Wang R; Zhu Z; Li F
    Clin Nucl Med; 2014 Jul; 39(7):605-8. PubMed ID: 24873787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ¹¹C-methionine and ¹⁸F-fluorodeoxyglucose positron emission tomography/CT in the evaluation of patients with suspected primary and residual/recurrent gliomas.
    Li DL; Xu YK; Wang QS; Wu HB; Li HS
    Chin Med J (Engl); 2012 Jan; 125(1):91-6. PubMed ID: 22340472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accumulation of
    Tomura N; Saginoya T; Mizuno Y; Goto H
    Acta Radiol; 2017 Mar; 58(3):362-366. PubMed ID: 27273374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of
    Wang Z; Mao Z; Zhang X; He D; Wang X; Du Q; Xiao Z; Zhu D; Zhu Y; Wang H
    Acad Radiol; 2019 Sep; 26(9):1222-1228. PubMed ID: 30318288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 11C-Methionine Positron Emission Tomography/Computed Tomography Versus 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Evaluation of Residual or Recurrent World Health Organization Grades II and III Meningioma After Treatment.
    Tomura N; Saginoya T; Goto H
    J Comput Assist Tomogr; 2018; 42(4):517-521. PubMed ID: 29613985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pituitary in nuclear medicine imaging.
    Iglesias P; Cardona J; Díez JJ
    Eur J Intern Med; 2019 Oct; 68():6-12. PubMed ID: 31519379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic accuracy of
    He Q; Zhang L; Zhang B; Shi X; Yi C; Zhang X
    BMC Cancer; 2019 Apr; 19(1):332. PubMed ID: 30961564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET/MRI in the Diagnosis of Hormone-Producing Pituitary Microadenoma: A Prospective Pilot Study.
    Wang H; Hou B; Lu L; Feng M; Zang J; Yao S; Feng F; Wang R; Li F; Zhu Z
    J Nucl Med; 2018 Mar; 59(3):523-528. PubMed ID: 28775202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 13N-Ammonia PET/CT for detection of recurrent glioma: a prospective comparison with contrast-enhanced MRI.
    Khangembam BC; Sharma P; Karunanithi S; Singhal A; Das CJ; Kumar P; Julka PK; Bandopadhyaya GP; Kumar R; Malhotra A; Bal C
    Nucl Med Commun; 2013 Nov; 34(11):1046-54. PubMed ID: 24025920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of 11C-Methionine and 18F-FDG PET/CT in Patients With Functioning Pituitary Adenomas.
    Feng Z; He D; Mao Z; Wang Z; Zhu Y; Zhang X; Wang H
    Clin Nucl Med; 2016 Mar; 41(3):e130-4. PubMed ID: 26646998
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Maccora D; Caldarella C; Calcagni ML
    Ann Nucl Med; 2021 Apr; 35(4):469-478. PubMed ID: 33491131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 11C-methionine PET for the diagnosis and management of recurrent pituitary adenomas.
    Tang BN; Levivier M; Heureux M; Wikler D; Massager N; Devriendt D; David P; Dumarey N; Corvilain B; Goldman S
    Eur J Nucl Med Mol Imaging; 2006 Feb; 33(2):169-78. PubMed ID: 16228237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative Evaluation of Sellar and Parasellar Macrolesions by [
    Tosaka M; Higuchi T; Horiguchi K; Osawa T; Arisaka Y; Fujita H; Tsushima Y; Yoshimoto Y
    World Neurosurg; 2017 Jul; 103():591-599. PubMed ID: 28427982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined trans-sphenoidal and simultaneous trans-ventricular-endoscopic decompression of a giant pituitary adenoma: case report.
    Ojha BK; Husain M; Rastogi M; Chandra A; Chugh A; Husain N
    Acta Neurochir (Wien); 2009 Jul; 151(7):843-7; discussion 847. PubMed ID: 19399366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of scan initiation timing after
    Nakajima R; Abe K; Momose M; Fukushima K; Matsuo Y; Kimura K; Kondo C; Sakai S
    Ann Nucl Med; 2017 Feb; 31(2):190-197. PubMed ID: 27885545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of TSH-secreting pituitary adenoma using 11C-methionine image subtraction.
    Gillett D; Senanayake R; MacFarlane J; van der Meulen M; Koulouri O; Powlson AS; Crawford R; Gillett B; Bird N; Heard S; Kolias A; Mannion R; Aloj L; Mendichovszky IA; Cheow H; Bashari WA; Gurnell M
    EJNMMI Res; 2022 May; 12(1):26. PubMed ID: 35524902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perfusion-metabolism coupling in recurrent gliomas: a prospective validation study with 13N-ammonia and 18F-fluorodeoxyglucose PET/CT.
    Khangembam BC; Karunanithi S; Sharma P; Kc SS; Kumar R; Julka PK; Kumar R; Bal C
    Neuroradiology; 2014 Oct; 56(10):893-902. PubMed ID: 24989883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.